STAGE IIIB CERVICAL CANCER FIGO 2018
Clinical trials for STAGE IIIB CERVICAL CANCER FIGO 2018 explained in plain language.
Never miss a new study
Get alerted when new STAGE IIIB CERVICAL CANCER FIGO 2018 trials appear
Sign up with your email to follow new studies for STAGE IIIB CERVICAL CANCER FIGO 2018, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New trial tests aggressive combo therapy to fight tough cervical cancers
Disease control Recruiting nowThis study is for people with cervical cancer that has spread to nearby tissues or lymph nodes. It compares two treatment plans that combine chemotherapy, radiation, and an immunotherapy drug called pembrolizumab. One plan adds extra chemotherapy and immunotherapy at the start. T…
Matched conditions: STAGE IIIB CERVICAL CANCER FIGO 2018
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Major asian study aims to standardize cervical cancer care
Knowledge-focused Recruiting nowThis project is creating a large registry to understand how internal radiation therapy (brachytherapy) is currently used to treat cervical cancer across Asia. It will collect treatment and outcome data from about 1,000 patients to identify best practices and areas for improvement…
Matched conditions: STAGE IIIB CERVICAL CANCER FIGO 2018
Sponsor: Tata Memorial Hospital • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:19 UTC